Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    " September 15, 2009":" October 15, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Completed Redirected High Affinity Gag‐Specific Autologous T Cells for HIV Gene Therapy
Condition: HIV Infections
Interventions: Biological: WT-gag-TCR modified T cells;   Biological: α/6-gag-TCR modified T cells;   Other: STI or Drug Holiday
2 Completed Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected Adults
Condition: HIV Infections
Interventions: Biological: PENNVAX-B;   Biological: IL-12 DNA plasmids
3 Completed Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1/2-uninfected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
4 Completed The St. Marys and The Mater Switch Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
5 Completed The Women's HIV SeroIncidence Study (ISIS)
Condition: HIV Infections
Intervention:
6 Unknown  Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
Condition: HIV Infections
Intervention: Drug: maraviroc (Selzentry)
7 Completed Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet
Conditions: HIV Prevention;   HIV Infections
Interventions: Drug: Tenofovir;   Drug: HEC Placebo;   Drug: Open label tenofovir tablet
8 Completed Study of Vitamin D Supplementation to Male HIV Sero-positive Patients
Condition: HIV Seropositive
Interventions: Drug: Rocaltrol;   Drug: Vitamin D;   Drug: Calcium
9 Completed HIV Testing in the Emergency Department at Baystate Medical Center: A Pilot Program
Condition: HIV Infections
Intervention:
10 Completed Pilot Study to Compare the Pharmacokinetics Parameters in Plasma and Intracellular of Raltegravir Administered Once a Day in Adult Patients Infected With HIV
Condition: HIV Infections
Intervention: Drug: Raltegravir
11 Completed Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens
Condition: HIV Infections
Interventions: Drug: Darunavir/ritonavir;   Drug: Lopinavir/ritonavir
12 Completed Pharmacokinetics of Lamivudine at Two Different Doses
Condition: HIV Infections
Intervention: Drug: Lamivudine (3TC)
13 Unknown  Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers
Conditions: HIV-1;   HIV Infections
Intervention: Biological: MVA.HIVA
14 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
15 Completed
Has Results
Durability of Adherence in Self-Management of HIV
Condition: HIV Infections
Intervention: Behavioral: CAP-IT
16 Completed Telephone Support to Improve Adherence to Anti-HIV Medications
Condition: HIV Infections
Interventions: Behavioral: Enhanced nursing telephone support;   Behavioral: Standard care
17 Completed The Maraviroc Central Nervous System (CNS) Study
Condition: HIV Infections
Intervention: Drug: Maraviroc
18 Completed
Has Results
The Raltegravir and Ribavirin Pharmacokinetics (PK) Study
Condition: HIV Infections
Interventions: Drug: Ribavirin;   Drug: Raltegravir
19 Completed
Has Results
Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune
Condition: HIV Infections
Intervention:
20 Completed IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
Condition: HIV Infections
Interventions: Drug: Raltegravir (RAL);   Drug: Atazanavir (ATV);   Drug: Ritonavir (RTV);   Drug: Tenofovir (TDF);   Drug: Etravirine (ETV);   Drug: Darunavir (DRV);   Drug: Maraviroc (MVC);   Drug: Lopinavir/ritonavir (LPV/r)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.